Homepage

Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries

Screening Compounds Building blocks

Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls

Company News & Media Contact us For suppliers Trends in discovery compounds

Homepage > Company > Media > Pharma News > 2016

Pharma News, 2016

Global Active Pharmaceutical Ingredients (API) Market Revenues to Reach US$ 143 Bn in 2016, With North America Accounting for 35% Revenue Shares

Global Active Pharmaceutical Ingredients (API) Market Revenues to Reach US$ 143 Bn in 2016, With North America Accounting for 35% Revenue Shares

NEW YORK, July 11, 2016 /PRNewswire/ -- According to a New Market Report Published by Persistence Market Research "Active Pharmaceutical Ingredient (API) Market" the Global Active Ph...

FDA Approves Shire’s Xiidra™ (lifitegrast ophthalmic solution) 5% – The Only Treatment Indicated for the Signs and Symptoms of Dry Eye Disease

FDA Approves Shire’s Xiidra™ (lifitegrast ophthalmic solution) 5% – The Only Treatment Indicated for the Signs and Symptoms of Dry Eye Disease

Lexington, Mass.

Nichi-Iko Pharmaceutical Co., Ltd to Acquire Sagent Pharmaceuticals for $21.75 Per Share in All Cash Transaction

Nichi-Iko Pharmaceutical Co., Ltd to Acquire Sagent Pharmaceuticals for $21.75 Per Share in All Cash Transaction

TOKYO & SCHAUMBURG, Ill.

Sage's drug for postpartum depression succeeds in mid-stage study

Sage's drug for postpartum depression succeeds in mid-stage study

Sage Therapeutics Inc said its lead drug alleviated symptoms of severe postpartum depression, meeting the main goal of a small mid-stage study and sending the company's shares soaring in morning t...

Amgen drug appears 'highly similar' to Humira: FDA staff

Amgen drug appears 'highly similar' to Humira: FDA staff

Amgen Inc's version of AbbVie Inc's Humira arthritis drug, the world's top-selling medicine, appears similar in potency and safety to the original product, U.

European Commission approves Zinbryta to treat relapsing forms of multiple sclerosis

European Commission approves Zinbryta to treat relapsing forms of multiple sclerosis

The European Commission (EC) has approved Zinbryta (daclizumab) for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS).

Women who take aspirin before sex are more likely to give birth to a baby boy

Women who take aspirin before sex are more likely to give birth to a baby boy

Women who take an aspirin before sex may increase the likelihood of conceiving a baby boy, suggest researchers.

Chinese API maker spanked in warning letter

Chinese API maker spanked in warning letter

Some FDA warning letters are long, drawn-out documents listing specific and multiple violations and sometimes offering a blueprint for fixing issues.

Alexion making €100M Ireland plant investment

Alexion making €100M Ireland plant investment

Great Britain’s decision to bail on the European Union has raised questions about pharma investment on the continent but not stopped pharma companies from wanting to build manufacturing facilities i...

Novo expanding massive Denmark plant

Novo expanding massive Denmark plant

Just weeks after kicking off construction of a nearly $2 billion API plant in the U.

UPDATED: Pfizer planning Ireland biologics plant expansion

UPDATED: Pfizer planning Ireland biologics plant expansion

Pfizer recently started work on a new U.

Formation Of The Melanin Discovered, Opens To New Development In Medicine, Cosmetics, Environmental Technology

Formation Of The Melanin Discovered, Opens To New Development In Medicine, Cosmetics, Environmental Technology

The formation of melanin, which is responsible in determining the hair and skin color of humans, is fully understood by the scientists in the new study.

26 27 28 293031 32 33 34